Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Renal cell carcinoma.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 1 | Renal cell carcinoma |
TFE3 function has not been fully characterized.
Renal cell carcinoma, Xp11-associated is associated with mutations in the TFE3 gene on chromosome X.
Genetic testing for TFE3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for renal cell carcinoma, Xp11-associated has been reported in the published literature.
No clinical trials have been registered for renal cell carcinoma, Xp11-associated.
157 publications have been identified in PubMed for renal cell carcinoma, Xp11-associated. Research spans Basic Science / Preclinical (26%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 41 | 26% |
Data assembled from 5 of 12 sources · Last updated Nov 2, 2026, 9:41 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Research summaries
39 |
25% |
Testing and diagnosis research | 28 | 18% |
Disease patterns and progression | 17 | 11% |
Clinical study results | 15 | 10% |
Patient case studies | 8 | 5% |
New treatment approaches | 6 | 4% |
Other research | 3 | 2% |
Du Y (2026). [PMID: 41540036](https://pubmed.ncbi.nlm.nih.gov/41540036/). *Cell Death Dis*. [Basic Science / Preclinical]
Yuan Y (2026). [PMID: 41203184](https://pubmed.ncbi.nlm.nih.gov/41203184/). *Cell Signal*. [Basic Science / Preclinical]
Yi X (2026). [PMID: 41580160](https://pubmed.ncbi.nlm.nih.gov/41580160/). *Toxicol Appl Pharmacol*. [Diagnostic / Biomarker]
Liu Z (2026). [PMID: 41312723](https://pubmed.ncbi.nlm.nih.gov/41312723/). *Mol Med Rep*. [Review / Meta-Analysis]
Li J (2026). [PMID: 41568676](https://pubmed.ncbi.nlm.nih.gov/41568676/). *Artif Cells Nanomed Biotechnol*. [Diagnostic / Biomarker]
Lobo A (2026). [PMID: 41790060](https://pubmed.ncbi.nlm.nih.gov/41790060/). *Am J Surg Pathol*. [Epidemiology / Natural History]
Rodriguez M (2026). [PMID: 41632099](https://pubmed.ncbi.nlm.nih.gov/41632099/). *Cancer*. [Review / Meta-Analysis]
Zhang M (2026). [PMID: 40704447](https://pubmed.ncbi.nlm.nih.gov/40704447/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Wu J (2026). [PMID: 41578672](https://pubmed.ncbi.nlm.nih.gov/41578672/). *Ann Med*. [Epidemiology / Natural History]
Trpkov K (2026). [PMID: 41384711](https://pubmed.ncbi.nlm.nih.gov/41384711/). *Histopathology*. [Review / Meta-Analysis]
AI-curated news mentioning renal cell carcinoma, Xp11-associated
Updated Oct 10, 2026
A study discusses the use of deceased donor interposition grafts to repair superior mesenteric artery injuries during cytoreductive nephrectomy for metastatic renal cell carcinoma. This research highlights a surgical approach that may improve outcomes in complex cases.
Recent research highlights the characteristics of TFEB-amplified renal cell carcinoma, noting the presence of focal rhabdoid features, hyaline globules, giant tumor cells, and osseous metaplasia. This study contributes to the understanding of this rare cancer subtype.
A case study highlights the occurrence of renal synovial sarcoma alongside renal cell carcinoma, providing insights into this rare cancer combination. This discovery may inform future research and clinical approaches to managing such cases.